- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00306722
An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Flexible Bronchoscopy
A Phase 3, Randomized, Double-Blind, Dose-Controlled Study To Assess The Efficacy And Safety Of AQUAVAN® (Fospropofol Disodium) Injection For Minimal-To-Moderate Sedation In Patients Undergoing Flexible Bronchoscopy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a phase 3, randomized, double-blind, dose-controlled study designed to evaluate the efficacy and safety of AQUAVAN 6.5 mg/kg compared to a minimally effective dose of AQUAVAN 2.0 mg/kg, both following pretreatment with an analgesic, fentanyl in patients who are undergoing flexible bronchoscopy.
Following completion of preprocedure assessments, patients will be randomly assigned to 1 of 2 treatment groups at a 2:3 (AQUAVAN initial dose 1 [2.0 mg/kg]:AQUAVAN initial dose 2 [6.5 mg/kg] allocation ratio on the day of the scheduled procedure. Randomization will be stratified by site.
A person skilled in airway management (such as a respiratory therapist, a study nurse, or a clinician) and authorized by the facility in which the colonoscopy is performed must be immediately available during the conduct of the study. All patients will be placed on supplemental oxygen via nasal cannula (4 L/min), and an ECG monitor, pulse oximeter, and blood pressure monitor will be attached prior to administration of study medication. All patients will receive analgesic pretreatment (fentanyl citrate injection for pain; lidocaine for topical anesthetic followed by the administration of study medication. Assessments will be made to evaluate the patients for levels of sedation, clinical benefit of sedation, and adverse events. Blood samples will be collected for PK analysis.
Study Type
Enrollment
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Alabama
-
Mobile, Alabama, United States, 36608
- Pulmonary Associates of Mobile, PC
-
-
Arizona
-
Phoenix, Arizona, United States, 85032
- Precision Trials
-
-
California
-
Laguna Hills, California, United States, 92653
- Saddleback Memorial Medical Center
-
Los Angeles, California, United States, 90033
- USC Health Science Campus (USC University Hospital)
-
-
Florida
-
Pensacola, Florida, United States, 32503
- Pensacola Research Consultants, Inc.
-
-
Georgia
-
Augusta, Georgia, United States, 30909
- Acute Care Consultants Inc.
-
-
Kentucky
-
Bowling Green, Kentucky, United States, 42101
- Graves-Gilbert Clinic
-
-
Maine
-
Auburn, Maine, United States, 04210
- Central Maine Pulmonary Associates
-
-
Maryland
-
Pittsfield, Maryland, United States, 01201
- Berkshire Medical Center
-
-
Michigan
-
Flint, Michigan, United States, 48503
- Hurley Medical Center
-
-
Montana
-
Butte, Montana, United States, 59701
- Keith Popovich, MD, PLLC
-
Missoula, Montana, United States, 59802
- International Heart Institue of MT Foundation
-
-
Nebraska
-
Omaha, Nebraska, United States, 68198
- University of Nebraska Medical Center
-
-
New York
-
Johnson City, New York, United States, 13790
- United Health Scrvices Hosptial, INC
-
-
North Carolina
-
Greenville, North Carolina, United States, 27834
- Brody School of Medicine
-
Winston-Salem, North Carolina, United States, 27103
- All-Trials Clinical Research, LLC
-
-
Ohio
-
Cincinnati, Ohio, United States, 45267
- University of Cincinnati, The University Hospital
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Medical University of South Carolina
-
Charleston, South Carolina, United States, 29406
- Lowcountry Lung & Critical Care, PA
-
Greenville, South Carolina, United States, 29605
- Greenville Hospital System
-
Spartanburg, South Carolina, United States, 29303
- Spartanburg Medical Research
-
Spartanburg, South Carolina, United States, 29303
- South Carolina Pharmaceutical Research
-
-
Texas
-
Galveston, Texas, United States, 77555
- The University of Texas Medical Branch Division of APICS
-
-
Virginia
-
Abingdon, Virginia, United States, 24210
- Johnston Memorial Hospital Pulmonary Research
-
Fredericksburg, Virginia, United States, 22401
- Pulmonary Associates of Fredericksburg, Inc.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patient must be able to understand, either orally or in writing, and be able to consent and complete the required assessments and procedures
- Patient provides signed/dated Informed Consent and Health Insurance Portability and Accountability Act of 1996 (HIPAA) authorization after receiving a full explanation of the extent and nature of the study.
- Patient must be at least 18 years of age at the time of screening.
- If female, patient must be surgically sterile, postmenopausal, or not pregnant or lactating and must have been using an acceptable method of birth control for at least 1 month prior to dosing, with a negative urine pregnancy test result at screening and predose.
- Patient meets American Society of Anesthesiologists (ASA) Physical Classification System status of P1 to P4.
Exclusion Criteria:
- Patient has a history of allergic reaction or hypersensitivity to any anesthetic agent or opioid.
- Patient does not meet nils per os (NPO) status per ASA guidelines or institution's guideline.
- Patient has a Mallampati Classification Score of 4; OR a Mallampati Classification Score of 3 AND a thyromental distance ≤4 cm, or for any other reason has a difficult airway, in the opinion of the Investigator.
- Patient has an abnormal, clinically significant 3-lead ECG finding at predosing period Day 0.
- Patient has participated in an investigational drug study within 1 month prior to study start.
- Patient is unwilling to adhere to pre- and postprocedural instructions.
- Patient for whom the use of fentanyl citrate injection (fentanyl) is contraindicated.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Sedation Success rate is defined as: Having 3 consecutive Modified Observer's Assessment of Alertness/Sedation (OAA/S) scale scores of ≤4 after administration of sedative medication
|
Completing the procedure
|
Without requiring the use of alternative sedative medication
|
Without requiring manual or mechanical ventilation
|
Secondary Outcome Measures
Outcome Measure |
---|
Treatment Success rate - Treatment Success is defined as a patient (i) completing the procedure (ii) without requiring alternative sedative medications AND (iii) without requiring manual or mechanical ventilation
|
Proportion of patients willing to be treated again with the same study sedative medication
|
Proportion of patients who do not recall being awake during the procedure
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3000-0524
- MGI 3000-0524
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anesthesia
-
Samsun UniversityCompletedAnesthesia | Regional Anesthesia | Anesthesia ManagementTurkey
-
Charite University, Berlin, GermanyCompletedAnesthesia, Local | Anesthesia | Anesthesia; Adverse EffectGermany
-
Novocol Pharmaceutical of Canada, Inc.CompletedAnesthesia, Local | Dental Anesthesia | Anesthesia, ReversalUnited States
-
Aligarh Muslim UniversityCompletedAnesthesia | Anesthesia Intubation Complication | Anesthesia; Adverse EffectIndia
-
Universitas Sebelas MaretIndonesia Endowment Fund for EducationNot yet recruitingAnesthesia | Anesthesia; Reaction
-
University of PecsCompleted
-
Hormozgan University of Medical SciencesUnknownAnesthesia | Anesthesia; FunctionalIran, Islamic Republic of
-
University of ChicagoRecruitingAnesthesia | Patient Satisfaction | Anesthesia Risks | Anesthesia Consent | Consent RetentionUnited States
-
Assistance Publique - Hôpitaux de ParisINSERM UMR-942, Paris, France; M3DISIMNot yet recruitingPrediction Models for Cardiovascular and Neurocognitive Disease Risk in the General Population (CME)Anesthesia, Local | AnesthesiaFrance
-
Matthew BorzageRecruitingAnesthesia | Anesthesia; ReactionUnited States
Clinical Trials on AQUAVAN® (fospropofol disodium) Injection
-
Eisai Inc.CompletedProcedural SedationUnited States
-
Eisai Inc.CompletedIntubation | Respiration, Artificial | Postoperative SedationUnited States
-
Eisai Inc.PPDCompletedCoronary Artery Bypass Surgery | Ischemic Coronary Artery Disease
-
Eisai Inc.CompletedColonic Polyps | ColonoscopyUnited States
-
Eisai Inc.CompletedConscious SedationUnited States
-
West China HospitalCompleted
-
Eisai Inc.Omnicare Clinical Research; MDS Pharma Services; Bio Analytical Research Corporation and other collaboratorsCompletedColonoscopy | Colon Polyps
-
Xiaobo Yang, MDRecruiting
-
Eisai Inc.PPD; Covance; Quest Pharmaceutical ServicesTerminated